Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

IGC Pharma (IGC) Depreciation & Amortization (IS) (2016 - 2017)

Historic Depreciation & Amortization (IS) for Pharma (IGC) over the last 5 years, with Q4 2017 value amounting to $4989.0.

  • Pharma's Depreciation & Amortization (IS) fell 9745.59% to $4989.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $20026.0, marking a year-over-year decrease of 9702.15%. This contributed to the annual value of $396346.0 for FY2017, which is 4561.22% down from last year.
  • As of Q4 2017, Pharma's Depreciation & Amortization (IS) stood at $4989.0, which was down 9745.59% from $4344.0 recorded in Q3 2017.
  • Pharma's 5-year Depreciation & Amortization (IS) high stood at $323778.0 for Q1 2015, and its period low was $4344.0 during Q3 2017.
  • For the 5-year period, Pharma's Depreciation & Amortization (IS) averaged around $138043.3, with its median value being $148352.5 (2013).
  • In the last 5 years, Pharma's Depreciation & Amortization (IS) soared by 3713.5% in 2016 and then plummeted by 9831.55% in 2017.
  • Pharma's Depreciation & Amortization (IS) (Quarter) stood at $147708.0 in 2013, then grew by 4.07% to $153725.0 in 2014, then dropped by 6.98% to $143000.0 in 2015, then skyrocketed by 37.13% to $196103.0 in 2016, then crashed by 97.46% to $4989.0 in 2017.
  • Its Depreciation & Amortization (IS) stands at $4989.0 for Q4 2017, versus $4344.0 for Q3 2017 and $5964.0 for Q2 2017.